PODCAST: Announcing Crowell & Moring’s Regulatory Forecast 2019
Client Alert | less than 1 min read | 02.28.19
On February 27, Crowell & Moring published its fifth annual Regulatory Forecast, exploring a diverse range of regulatory developments coming out of Washington and other leading regulatory centers of power.
The publication’s editors, Richard Lehfeldt and Dan Wolff, both partners in the firm’s Administrative Law and Regulatory Practice, sat down to discuss the forecast. In this 21 minute podcast, Richard and Dan discuss what you will find in our Regulatory Forecast 2019.
Click below to listen or access from the link:
SoundCloud
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
